ScholarLens Back to search
2007•The Journal of School NursingRequires access

What School Nurses Need to Know About Cervical Cancer, HPV, and the New Vaccine

Jeanie Ehrhardt

Open publisher page 8 citations

Abstract

At least 12,000 women are diagnosed with cervical cancer each year in the United States, accounting for at least 4,000 deaths. Worldwide, cervical cancer is the second most common type of cancer among women. The human papilloma virus (HPV) has been linked to at least 70% of all cervical cancer. HPV can be divided into 2 categories: (a) low risk, which is responsible for genital warts, and (b) high risk, which is responsible for cervical cancer. An effective new vaccine has been approved that will decrease the spread of infection caused by HPV, therefore decreasing the future incidence of cervical cancer and genital warts. Understanding the risks of acquiring HPV and the increased risk for cervical cancer may lead to enhanced vaccine acceptance.

About this research paper

What this paper is about

At least 12,000 women are diagnosed with cervical cancer each year in the United States, accounting for at least 4,000 deaths. Worldwide, cervical cancer is the second most common type of cancer among women. The human papilloma virus (HPV) has been linked to at least 70% of all cervical cancer. HPV can be divided into 2 categories: (a) low risk, which is responsible for genital warts, and (b) high risk, which is responsible for cervical cancer. An effective new vaccine has been approved that will decrease the spread of infection caused by HPV, therefore decreasing the future incidence of cervical cancer and genital warts. Understanding the risks of acquiring HPV and the increased risk for cervical cancer may lead to enhanced vaccine acceptance.

Why it matters

OpenAlex reports 8 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

At least 12,000 women are diagnosed with cervical cancer each year in the United States, accounting for at least 4,000 deaths. Worldwide, cervical cancer is the second most common type of cancer among women. The human papilloma virus (HPV) has been linked to at least 70% of all cervical cancer. HPV can be divided into 2 categories: (a) low risk, which is responsible for genital warts, and (b) high risk, which is responsible for cervical cancer. An effective new vaccine has been approved that will decrease the spread of infection caused by HPV, therefore decreasing the future incidence of cervical cancer and genital warts. Understanding the risks of acquiring HPV and the increased risk for cervical cancer may lead to enhanced vaccine acceptance.

Key concepts: Cervical cancer, Medicine, Genital warts, Human papilloma virus, Incidence (geometry), Cancer, Sex organ, HPV vaccines

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
What School Nurses Need to Know About Cervical Cancer, HPV, and the New Vaccine — Research Paper | ScholarLens